pulmonary and intranasal administration Flashcards
what factors affect deposition?
- Environmental humidity
- chemical composition
- solvent evaporation
- aerosol velocity
- respiratory tract physiology
why does environmental humidity affect deposition?
the lungs have a higher humidity so condensation of water on particle surface will occur as particles move to high humidity
water-soluble particles will also grow in size and affect where deposition occurs
how do hydrophobic and hydrophilic particles differ with deposition in the body?
hydrophobic particles will sit on the water surface
hydrophilic will solublise in the humid environment of the lungs
why does solvent evaporation affect deposition?
important for pMDI devices
- the propellant in these devices mean a large size droplet will have not enough time for propellant evaporation and this impact where it deposits
it will most likely deposit in the back of the throat
why does chemical composition affect deposition?
pMDI drug suspensions can have physical instability such as flocculation, bulk separation, irreversible aggregation
this increases suspended particles size’ and where they are released so could be deposited in the wrong part of the lung or the throat
why does aerosol velocity affect deposition?
there is a high initial velocity of aerosol leaving the inhaler
- they have an increased momentum and will evaporate quicker
can cause them to deposit ay back of the throat as they cant change direction to go back into the lung
why does respiratory tract physiology affect deposition?
anatomical and physiological differences influence deposition;
- age
- gender
- body size
- ethnicity
- lung state
what methods can improve deposition?
- Spacer devices
- reduces droplet velocity and allows propellant evaporation - breath-actuated pMDI devices
- device first at correct points of inspiratory cycle - breathing patterns
- slow, deep inhalation followed by breath-hold
- breath holding allows deposition by diffusion and sedimentation to occur
- allows greater peripheral distribution of particles to occur and and increase inhalation flow rate increases deposition
- too rapid can cause back of the throat deposition
how can you assess deposition?
using gamma scintigraphy
- measures deposition in lung, stomach etc.
- krypton gas used and radio labelled with technetium 99m
- can use MSLI, NGI, TSI, ACI to measure particle size used and clinical performance
what are dis/advantages of the pulmonary route?
\+ non-invasive and easily accessible \+ can give low doses as had rapid uptake and OoA \+ lower proteolytic activity than GI \+ avoids first pass metabolism - poor reproducibility - ability of lung macrophages to engulf particles - inefficiency of drug delivery devices - metabolic capacity of lungs
what delivery method do most devices aim for?
pulmonary drug delivery as it allows delivery to the central regions of the lung
new delivery devices are needed for systemic delivery
why should you use nasal administration?
it has quick systemic absorption so get to the brain quicker
- convenient
- useful area for absorption
- good systemic blood flow
what kind of nasal preparations can you get?
you can get preparation used for nasal mucosa e.g. antibiotics, antihistamines
can be administered as in solution form in drops or sprays
can get suspensions, gels, ointments, creams and dry powders can also be used
what are the limitations to nasal delivery?
- many drugs aren’t absorbed
- can have nasal irritation
- some drugs might undergo nasal metabolism
- the lack of aqueous solubility might be a problem
what are the functions of the nose?
it is a sensory organ so detects olfactory stimuli
- > filters against airborne particles
- > generates turbulent flow
- > chemical sensor for environmental irritants
how does nasal deposition occur?
initial removal is by the nasal hairs
then further deposition occurs by inertial impaction; for particles >1mm
- optimum particle size is 10mm
what is the primary site of deposition and absorption?
- the respiratory epithelium
has columnar cells that are ciliated and goblet and basal cells that secrete mucus
what factors can affect absorption?
- foreign materials trapped in viscous mucous
- much moved from nasal cavity to nasopharynx via mucociliary transport
- epithelium is an extra barrier to absorption
how can you improve nasal absorption?
- increase nasal residence time
- enhance nasal absorption
- modify drug structure to change physiochemical properties
what are physicochemical factors and what effect do they have on nasal absorption?
- effect of size and MW
- > amount of drug absorbed is inversely proportional to the MW
- >important for absorption of small hydrophilic drugs
- >absorption occurs through aqueous channels between cells - effect of pH and partition coefficient
- > most drugs can be ionised
- > partition coefficient depends on environmental pH
- > depends on degree of ionisation ; hydrophilic drugs use aqueous channels - effect of lipophilicity
- higher lipophilicity means faster absorption
- drug must be ionised to be absorbed effectively
how can you increase residence time?
- apply the drug to the anterior part of the nasal cavity ; depends on drug delivery system
- metered- dose pumps have greatest control of direction and drops are inaccurate and too rapid - reduce rate of clearance
- use microsphere technology
- use gel formulation to increase viscosity
how can you enhance nasal absorption?
- absorption enhancers; alters epithelial cell structure to increase rate
- > disrupts membranes, inhibits enzymes and opens tight junctions - surfactants; but can cause mucosal damage
- bile salts are more effective and less damage but can damage epithelial cells
- phosphatidylcholine can enhance absorption without causing damage; can carry the drug across membrane with them
how could you modify drug structure for better delivery and absorption?
- alter the solubility or partition coefficient; salt formation or changing substituent groups
- use cyclodextrins ; increases drug bioavailability by increasing aqueous solubility
- use pro-drug technology
- > add bio-cleavage group to drug
- has better absorption properties
- metabolised to active drugs in nasal epithelium